Cariporide given during resuscitation promotes return of electrically stable and mechanically competent cardiac activity

Resuscitation

Volumn 81, Issue 1, 2010, Pages 106-110

  Ayoub, Iyad M ^a,b   Kolarova, Julieta ^a,b   Gazmuri, Raúl J ^a,b  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Arrhythmia; Cardiac arrest; Cardiopulmonary resuscitation; Cariporide; Myocardial stunning; Sodium hydrogen antiporter; Ventricular dysfunction; Ventricular fibrillation

Indexed keywords

CARIPORIDE; SODIUM CHLORIDE; SODIUM PROTON EXCHANGE PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA PRESSURE; ARTICLE; CARDIOVERSION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HEART ARREST; HEART CONTRACTION; HEART INDEX; HEART STROKE VOLUME; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; MALE; NONHUMAN; PRIORITY JOURNAL; RECURRENT DISEASE; RESUSCITATION; SWINE;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; CARDIOPULMONARY RESUSCITATION; GUANIDINES; HEART MASSAGE; MALE; STATISTICS, NONPARAMETRIC; SULFONES; SURVIVAL RATE; SWINE; VENTRICULAR FIBRILLATION;

EID: 72049086939     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2009.09.013     Document Type: Article

References (23)

1. van Alem A.P., Post J., and Koster R.W. VF recurrence: characteristics and patient outcome in out-of-hospital cardiac arrest. Resuscitation 59 (2003) 181-188
2. Opie L.H., and Clusin W.T. Cellular mechanism for ischemic ventricular arrhythmias. Annu Rev Med 41 (1990) 231-238
3. Shivkumar K., Deutsch N.A., Lamp S.T., Khuu K., Goldhaber J.I., and Weiss J.N. Mechanism of hypoxic K loss in rabbit ventricle. J Clin Invest 100 (1997) 1782-1788
4. An J., Varadarajan S.G., Camara A., et al. Blocking Na(+)/H(+) exchange reduces [Na(+)](i) and [Ca(2+)](i) load after ischemia and improves function in intact hearts. Am J Physiol 281 (2001) H2398-H2409
5. Kusuoka H., Chacko V.P., and Marban E. Myocardial energetics during ventricular fibrillation investigated by magnetization transfer nuclear magnetic resonance spectroscopy. Circ Res 71 (1992) 1111-1122
6. Imahashi K., Kusuoka H., Hashimoto K., Yoshioka J., Yamaguchi H., and Nishimura T. Intracellular sodium accumulation during ischemia as the substrate for reperfusion injury. Circ Res 84 (1999) 1401-1406
7. Gazmuri R.J., Ayoub I.M., Kolarova J.D., and Karmazyn M. Myocardial protection during ventricular fibrillation by inhibition of the sodium-hydrogen exchanger isoform-1. Crit Care Med 30 (2002) S166-S171
8. Karmazyn M., Sawyer M., and Fliegel L. The na(+)/h(+) exchanger: a target for cardiac therapeutic intervention. Curr Drug Targets Cardiovasc Haematol Disord 5 (2005) 323-335
9. Gazmuri R.J., Weil M.H., Bisera J., Tang W., Fukui M., and McKee D. Myocardial dysfunction after successful resuscitation from cardiac arrest. Crit Care Med 24 (1996) 992-1000
10. Kern K.B., Hilwig R.W., Rhee K.H., and Berg R.A. Myocardial dysfunction after resuscitation from cardiac arrest: an example of global myocardial stunning. J Am Coll Cardiol 28 (1996) 232-240
11. Laurent I., Monchi M., Chiche J.D., et al. Reversible myocardial dysfunction in survivors of out-of-hospital cardiac arrest. J Am Coll Cardiol 40 (2002) 2110-2116
12. Gazmuri R.J., Ayoub I.M., Hoffner E., and Kolarova J.D. Successful ventricular defibrillation by the selective sodium-hydrogen exchanger isoform-1 inhibitor cariporide. Circulation 104 (2001) 234-239
13. Franz M.R. Current status of monophasic action potential recording: theories, measurements and interpretations. Cardiovasc Res 41 (1999) 25-40
14. Ayoub I.M., Kolarova J.D., Yi Z., et al. Sodium-hydrogen exchange inhibition during ventricular fibrillation: beneficial effects on ischemic contracture, action potential duration, reperfusion arrhythmias, myocardial function, and resuscitability. Circulation 107 (2003) 1804-1809
15. Ayoub I.M., Kolarova J.D., Sehgal M.A., Sanders R., Sheth O., and Gazmuri R.J. Sodium-hydrogen exchange inhibition minimizes adverse effects of epinephrine during cardiac resuscitation. Circulation 108 (2003) IV-420
16. Wirth K.J., Maier T., and Busch A.E. NHE1-inhibitor cariporide prevents the transient reperfusion-induced shortening of the monophasic action potential after coronary ischemia in pigs. Basic Res Cardiol 96 (2001) 192-197
17. Xu T., Tang W., Ristagno G., Wang H., Sun S., and Weil M.H. Postresuscitation myocardial diastolic dysfunction following prolonged ventricular fibrillation and cardiopulmonary resuscitation. Crit Care Med 36 (2008) 188-192
18. 2+ accumulation and attenuates myocardial injury. J Appl Physiol 103 (2007) 55-65
19. Ayoub I.M., Kolarova J., Kantola R.L., Sanders R., and Gazmuri R.J. Cariporide minimizes adverse myocardial effects of epinephrine during resuscitation from ventricular fibrillation. Crit Care Med 33 (2005) 2599-2605
20. Ayoub I.M., Kolarova J., Kantola R., Radhakrishnan J., and Gazmuri R.J. Zoniporide preserves left ventricular compliance during ventricular fibrillation and minimizes post-resuscitation myocardial dysfunction through benefits on energy metabolism. Crit Care Med 35 (2007) 2329-2336
21. Kato R., and Foex P. Myocardial protection by anesthetic agents against ischemia-reperfusion injury: an update for anesthesiologists. Can J Anaesth 49 (2002) 777-791
22. Gazmuri R.J., and Ayoub I.M. The case for sodium-hydrogen exchanger isoform-1 inhibition during cardiac resuscitation remains strong. Crit Care Med 34 (2006) 1580-1582
23. Idriss S.F., Anstadt M.P., Anstadt G.L., and Ideker R.E. The effect of cardiac compression on defibrillation efficacy and the upper limit of vulnerability. J Cardiovasc Electrophysiol 6 (1995) 368-378